logo-loader
viewOpen Orphan PLC

Open Orphan confirms Leo Toole as chief financial officer

Bringing more than 20 years’ experience, Toole previously held roles with Procter and Gamble, ResMed and Sublimity Therapeutics

Open Orphan PLC -
There will be a new face around the Open Orphan boardroom table

Open Orphan PLC (LON:ORPH) has appointed interim chief financial officer Leo Toole to the position full time.

Bringing more than 20 years’ experience, Toole previously held roles with Procter and Gamble, ResMed and Sublimity Therapeutics.

He will be appointed to the board “as soon as possible”, the pharmaceutical services company said.

"I am delighted that we have appointed Leo as CFO,” said Open Orphan chairman Cathal Friel.

“He has worked with Open Orphan for the past year and is therefore well placed to assist with the rapid integration of hVIVO, deliver on our synergies programme and target profitability in the near term.

“We feel he is an important addition to the executive team as we target the rapidly growing CRO pharmaceutical services sector."

Quick facts: Open Orphan PLC

Price: 5.9 GBX

AIM:ORPH
Market: AIM
Market Cap: £32.39 m
Follow

NO INVESTMENT ADVICE

The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...

In exchange for publishing services rendered by the Company on behalf of Open Orphan PLC named herein, including the promotion by the Company of Open Orphan PLC in any Content on the Site, the Company receives from...

FOR OUR FULL DISCLAIMER CLICK HERE

Watch

Open Orphan catching global attention with 'stunning' FLU-v results &...

Open Orphan PLC's (LON:ORPH) Cathal Friel and its subsidiary hVIVO's chief scientist Dr Andrew Catchpole sat down with Proactive London's Andrew Scott. This morning Open Orphan announced the results from a clinical trial of a broad-spectrum flu jab that they're jointly developing have been...

3 weeks, 4 days ago

2 min read